JENNIFER AUDIBERT: Open Payments
NPI 1568414399 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 16 payments from 10 companies in 2025. Trend: 2023 $393 · 2024 $390 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $78 |
| Amgen Inc. | 2 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Abbott Laboratories | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Wegovy, REPATHA, LifeVest, CAMZYOS, AVEIR, NEXLETOL, LEQVIO, Attruby.
Industry payments across VA — which companies pay providers there.
